Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia.

Abstract

VGA1155 was found to protect against secondary ischemic brain damage after permanent focal cerebral ischemia, although it did not reduce vasogenic edema at 24 hours. Changes in endogenous VEGF may be related to the therapeutic effect of VGA1155.